Altimmune, Inc. (ALT) is a biotechnology company focused on the development of immunotherapies and therapeutic products. The company specializes in the development of vaccines and therapeutics aimed at boosting the immune system and combating various infectious diseases. Their research spans areas such as respiratory diseases, hepatitis B, and other health challenges. Altimmune strives to innovate in the field of immunotherapy and introduce new treatment possibilities. The company leverages modern technologies and scientific research to achieve its goals. Investors interested in the biotechnology sector and healthcare innovations might see potential in Altimmune, Inc. (ALT) shares for growth in this dynamic field.